util
celllevel
approach
examin
glycolyt
pathway
dlpfc
subject
schizophrenia
control
subject
found
decreas
mrna
express
glycolyt
enzym
pyramid
neuron
astrocyt
replic
novel
bioenerget
find
probe
independ
dataset
bioenerget
target
found
similar
abnorm
next
use
novel
strategi
build
schizophrenia
bioenerget
profil
tailor
applic
librari
integr
networkbas
cellular
signatur
data
portal
ilinc
investig
connect
cellular
pathway
kinas
transcript
factor
use
enrichr
final
goal
identifi
drug
capabl
revers
bioenerget
schizophrenia
signatur
perform
connect
analysi
ilinc
identifi
peroxisom
proliferatoractiv
receptor
ppar
agonist
promis
therapeut
target
administ
ppar
agonist
knockdown
model
schizophrenia
found
improv
longterm
memori
taken
togeth
find
suggest
tailor
bioinformat
approach
coupl
linc
librari
transcript
signatur
chemic
genet
perturbagen
may
employ
identifi
novel
treatment
strategi
schizophrenia
relat
diseas
schizophrenia
devast
ill
affect
million
peopl
us
display
wide
rang
symptom
cognit
impair
hallmark
featur
ill
antipsychot
poor
efficaci
treat
cognit
declin
dorsolater
prefront
cortex
dlpfc
brain
region
heavili
implic
pathophysiolog
schizophrenia
possibl
contribut
defect
work
memori
varieti
abnorm
report
dlpfc
schizophrenia
patient
includ
chang
gene
express
cell
densiti
receptor
bind
cerebr
blood
flow
also
accumul
evid
bioenerget
dysfunct
chronic
schizophrenia
recent
review
highlight
number
abnorm
associ
glucos
metabol
lactat
shuttl
bioenerget
coupl
also
evid
genet
linkag
enzym
control
glycolysi
schizophrenia
includ
hexokinas
suggest
genet
risk
ill
includ
bioenerget
substrat
interestingli
studi
use
celllevel
techniqu
demonstr
complex
bioenerget
chang
includ
decreas
mitochondri
oxid
energi
metabol
gene
dentat
granul
neuron
layer
pyramid
neuron
dlpfc
decreas
metabol
transcript
includ
lactat
dehydrogenas
ldha
nicotinamid
adenin
dinucleotid
dehydrogenas
nadh
atp
synthas
also
recent
demonstr
decreas
glycolyt
enzym
phosphofructokinas
muscl
type
pfkm
glucos
transport
pyramid
neuron
astrocyt
dlpfc
schizophrenia
subject
examin
express
individu
target
import
employ
signatur
base
bioinformat
approach
may
help
elucid
pathophysiolog
larg
biolog
network
gene
determin
knockdown
signatur
catalogu
databas
cluster
seed
gene
knockdown
signatur
ilinc
abl
analyz
connect
knockdown
signatur
thu
establish
schizophrenia
bioenerget
profil
identifi
group
gene
chang
concordantli
follow
genet
perturb
furthermor
perform
enrichr
analys
gene
gain
perspect
bioenerget
patholog
describ
potenti
multisystem
patholog
mechan
inform
pharmacolog
studi
next
aim
identifi
therapeut
compound
potenti
revers
glycolyt
deficit
well
associ
chang
gene
order
select
potenti
drug
intervent
preclin
test
reli
connect
analysi
reveal
posit
concord
neg
correl
discord
chemic
small
molecul
genet
perturb
develop
discoveri
base
workflow
gener
list
small
molecul
perturbagen
transcript
chang
opposit
direct
knockdown
signatur
base
concord
valu
ilinc
ie
gener
inversediscord
signatur
figur
ilinc
provid
transcriptom
profil
signatur
cell
line
follow
treatment
chemic
perturbagen
fda
approv
drug
chemic
probe
screen
librari
compound
includ
clinic
util
known
mechan
action
fda
approv
drug
gener
knockdown
signatur
connect
analysi
could
serv
candid
therapeut
treatment
preclin
model
schizophrenia
peroxisom
proliferatoractiv
receptor
ppar
agonist
multipl
hit
analysi
similar
drug
class
current
fda
approv
use
human
one
lead
hypothes
etiolog
schizophrenia
glutamaterg
hypofunct
nmethyldaspart
subtyp
glutam
nmda
receptor
dysfunct
strongli
implic
pathophysiolog
schizophrenia
particularli
human
pharmacolog
studi
converg
evid
suggest
nmda
receptor
hypofunct
may
actual
reflect
dysregul
receptor
level
includ
mutat
nmda
receptor
subunit
sever
studi
found
associ
gene
encod
subunit
nmda
receptor
schizophrenia
knockdown
mous
model
global
reduct
normal
function
nmda
receptor
achiev
target
insert
kb
foreign
dna
intron
gene
addit
mice
mutat
gene
wellcharacter
behavior
endophenotyp
schizophrenia
includ
impair
execut
function
work
memori
increas
stereotyp
behavior
decreas
anxietylik
behavior
decreas
sensorimotor
gate
abnorm
social
interact
sever
behavior
attenu
typic
atyp
antipsychot
dose
similar
use
pharmacolog
model
schizophrenia
phencyclidin
model
includ
hyperact
stereotypi
sociabl
deficit
therefor
knockdown
mous
model
viabl
use
tool
studi
interfac
nmda
receptor
hypofunct
bioenerget
schizophrenia
symptomolog
evid
abnorm
bioenerget
pathway
knockdown
anim
model
impair
synaps
exampl
strong
evid
link
lactat
shuttl
defect
nmda
receptor
dysfunct
treat
rat
subunit
knockdown
mice
dysregul
energet
flow
lactat
inhibit
long
term
potenti
may
contribut
cognit
deficit
knockdown
mice
addit
lactat
flow
astrocyt
neuron
stimul
lactat
introduc
extracellular
space
enhanc
work
memori
memori
format
rat
thu
druginduc
stimul
lactat
product
coupl
behavior
studi
knockdown
mice
could
help
elucid
role
bioenerget
abnorm
cognit
dysfunct
schizophrenia
pioglitazon
member
thiolazinedion
tzd
drug
famili
appear
knockdown
signatur
connect
analysi
approv
treat
type
diabet
hyperglycemia
pioglitazon
synthet
ligand
nuclear
receptor
respons
regul
sever
bioenerget
function
lipid
homeostasi
adipocyt
differenti
insulin
sensit
interestingli
agonist
abil
reduc
oxid
stress
via
mediat
nitric
oxid
product
well
modifi
mitochondri
metabol
interact
protein
associ
mitochondri
function
mitoneet
protein
activ
via
pioglitazon
also
alter
transcript
express
lead
chang
glucos
uptak
mechan
thu
hypothes
treatment
pioglitazon
help
restor
cognit
endophenotyp
associ
schizophrenia
knockdown
model
via
stimul
metabol
pathway
final
experi
treat
anim
pioglitazon
measur
variou
behavior
output
endophenotyp
schizophrenia
first
assess
locomotor
activ
stereotyp
behavior
manialik
behavior
next
assess
execut
function
cognit
flexibl
use
puzzlebox
test
test
requir
mous
display
problemsolv
behavior
well
shortand
longterm
explicit
memori
reach
goal
area
assess
pioglitazon
effect
sociabl
use
ageand
sexmatch
mous
social
stimulu
final
assess
sensorimotor
gate
use
prepuls
inhibit
ppi
acoust
startl
paradigm
taken
togeth
studi
provid
bioinformat
translat
approach
identifi
novel
treatment
strategi
use
linc
librari
signatur
connect
analysi
coupl
analys
primari
data
publish
work
extend
set
seed
gene
use
laser
captur
microdissect
coupl
quantit
polymeras
chain
reaction
lcmqpcr
assess
mrna
express
metabol
target
enrich
popul
astrocyt
pyramid
neuron
schizophrenia
control
subject
tabl
previous
shown
lcm
sampl
enrich
specif
cellsubtyp
use
neurochem
marker
signific
associ
found
ph
postmortem
interv
pmi
rna
integr
number
rin
age
depend
measur
sampl
enrich
pyramid
neuron
found
decreas
pfkl
gpi
mrna
express
figur
p
detect
signific
chang
mrna
express
sampl
enrich
astrocyt
figur
assess
use
antipsychot
medic
patient
popul
reanalyz
signific
celllevel
target
without
antipsychot
subject
find
remain
signific
without
subject
pfkl
gpi
figur
panel
b
also
assess
effect
antipsychot
pfkl
gpi
across
multipl
brain
region
stanley
medic
research
institut
genom
databas
detect
effect
gpi
fold
pfkl
fold
howev
effect
opposit
direct
find
suggest
decreas
express
pyramid
neuron
schizophrenia
due
medic
effect
addit
assess
effect
ethanol
use
smoke
later
depend
measur
schizophrenia
subject
via
secondari
analys
schizophrenia
subject
ethanol
smokersnonsmok
leftright
brain
detect
effect
figur
panel
ch
built
schizophrenia
bioenerget
gene
profil
glycolyt
gene
base
data
celllevel
postmortem
find
pfkm
pfkl
gpi
literatur
ldha
seed
gene
use
subsequ
lookup
replic
studi
ilinc
cluster
analys
follow
enrichr
analysi
ilinc
connect
analys
drug
discoveri
analysi
use
inversediscord
signatur
figur
summar
bioinformat
work
flow
cluster
connect
analys
replic
bioenerget
find
perform
silico
valid
studi
lookup
studi
use
three
independ
dataset
stanley
medic
research
institut
smri
mount
sinai
school
medicin
mssm
frontal
cortic
neuron
rnaseq
dataset
gener
ipsc
patient
schizophrenia
mutat
tabl
summar
find
studi
previou
studi
laboratori
well
mrna
express
select
seed
gene
ldha
pfkm
pfkl
gpi
dataset
ldha
significantli
downregul
smri
fc
frontal
cortic
neuron
mrna
fc
dataset
downregul
mssm
microarray
dataset
fc
mani
seed
gene
unchang
smri
mssm
dataset
howev
smri
databas
aggreg
brain
region
mssm
dataset
util
blend
sampl
whole
dlpfc
find
celllevel
studi
support
seed
gene
fold
chang
threshold
celllevel
frontal
cortic
neuron
dataset
use
ilinc
http
ilincsorg
retriev
knockdown
signatur
seed
gene
individu
seed
gene
knockdown
signatur
gpi
knockdown
signatur
knockdown
signatur
pfkm
knockdown
signatur
pfkl
knockdown
signatur
ldha
knockdown
signatur
knockdown
signatur
compris
transcript
chang
landmark
gene
gene
seed
gene
knock
figur
signatur
design
reproduc
selfconnect
gold
broad
institut
avail
multipl
shrna
avail
gene
knockdown
experi
consensu
gene
knockdown
signatur
defin
ilinc
use
minim
variabl
compar
signatur
seed
gene
use
one
consist
cell
line
vertebralcanc
prostat
vcap
unsupervis
cluster
analys
use
ilinc
cluster
union
top
differenti
express
gene
seed
gene
knockdown
signatur
use
pearson
correl
coeffici
figur
due
gene
overlap
top
differenti
express
gene
seed
gene
knockdown
signatur
result
cluster
express
data
gene
next
use
dendrogram
function
ilinc
select
panel
mrna
increas
express
across
cluster
seed
gene
knockdown
signatur
panel
cluster
upregul
gene
decreas
express
across
cluster
seed
gene
knockdown
signatur
panel
cluster
downregul
gene
cluster
gene
panel
tabl
carri
forward
two
separ
enrichr
analys
perform
enrichr
analys
panel
cluster
upregul
gene
ilinc
cluster
analysi
top
cell
signal
pathway
includ
forkhead
box
foxo
mitogenactiv
protein
kinas
mapk
wnt
signal
pathway
figur
pathway
often
interact
import
role
cell
metabol
inflamm
cellular
prolifer
oxid
stress
prevent
apoptosi
analysi
gene
ontolog
go
cellular
compon
panel
cluster
upregul
gene
includ
sever
microtubul
cytoskelet
compon
figur
top
hit
go
molecular
function
includ
protein
kinas
c
pkc
mapk
bind
figur
proteinprotein
interact
analysi
figur
yield
multipl
hit
protein
kinas
also
found
hit
protein
involv
protein
degrad
protein
ubiquitin
chromatin
remodel
pcna
estrogen
receptor
next
probe
kinas
knock
variou
cell
line
upregul
gene
similar
panel
cluster
upregul
gene
ilinc
cluster
analysi
top
hit
includ
sever
serinethreonineprotein
kinas
atr
well
gprotein
coupl
receptor
gpcr
involv
energi
homeostasi
figur
next
probe
transcript
factor
occup
site
panel
cluster
upregul
gene
found
sever
transcript
factor
play
import
role
development
process
nfib
figur
final
databas
genotyp
phenotyp
dbgap
analysi
implic
diabet
relev
phenotyp
figur
summari
find
found
tabl
perform
enrichr
analys
panel
cluster
downregul
gene
ilinc
cluster
analysi
top
cell
signal
pathway
includ
pathway
relev
immuneinflammatori
respons
cell
cycl
regul
figur
top
hit
go
cellular
compon
analysi
panel
cluster
downregul
gene
implic
mitochondri
function
figur
top
hit
go
molecular
function
includ
sever
rna
polymeras
promotorsactiv
figur
proteinprotein
interact
analysi
figur
yield
multipl
hit
chromatin
remodel
protein
pcna
crebbp
also
found
hit
protein
involv
immunitycel
cycl
regul
myc
ubiquitin
next
probe
kinas
knock
variou
cell
line
downregul
gene
similar
panel
cluster
downregul
gene
ilinc
cluster
analysi
top
hit
includ
sever
kinas
involv
fatti
acid
metabol
energi
homeostasi
rxra
pparg
pxk
cellular
growth
ryk
gpcr
glucocorticoid
receptor
figur
next
probe
transcript
factor
occup
site
panel
cluster
downregul
gene
found
sever
transcript
factor
play
import
role
cell
prolifer
mycn
myc
develop
erythroid
function
eklf
figur
final
dbgap
analysi
implic
carcinoma
memori
grave
diseas
relev
phenotyp
figur
summari
find
found
tabl
use
connect
signatur
function
ilinc
identifi
chemic
perturbagen
produc
signatur
highli
discord
anticorrel
seed
gene
next
combin
discord
perturbagen
tabl
report
top
overal
discord
perturbagen
signatur
across
seed
gene
knockdown
signatur
tabl
remov
duplic
hit
uniqu
perturbagen
remain
tabl
hit
includ
agonist
troglitazon
genistein
valproic
acid
voltageg
sodium
channel
blocker
hdac
inhibitor
typic
antipsychot
drug
trifluoperazin
thioridazin
fluphenazin
two
inhibitor
wortmannin
select
fda
approv
agonist
pioglitazon
preclin
trial
due
abil
regul
glycolyt
pathway
abnorm
schizophrenia
well
evid
pioglitazon
treatment
improv
neg
symptom
patient
cognit
studi
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cohort
mice
separ
pioglitazon
studi
use
mous
antibodi
captur
protein
complex
sampl
male
wt
male
knockdown
affin
purifi
sampl
enrich
compar
supernat
total
homogen
figur
follow
mass
spectrometri
affin
purifi
sampl
analyz
top
increas
protein
knockdown
mice
rel
wt
mice
ingenu
pathway
analysi
ipa
top
implic
pathway
knockdown
mice
gluconeogenesi
glucos
metabol
pyruv
citric
acid
metabol
metabol
carbohydr
glycogen
storag
diseas
figur
final
examin
mrna
express
metabol
transport
use
real
time
quantit
polymeras
chain
reaction
rtqpcr
cohort
knockdown
wildtyp
wt
mice
per
group
found
signific
decreas
knockdown
mice
compar
wt
control
figur
confirm
strategi
increas
glucos
uptak
capac
might
success
intervent
schizophrenia
pioglitazon
studi
differ
cohort
mice
tabl
assess
calor
intak
bodi
weight
ensur
pioglitazon
treatment
advers
effect
pioglitazon
affect
intak
chow
bodi
weight
anim
figur
puzzl
box
assay
found
one
week
pioglitazon
treatment
decreas
improv
time
perform
task
mice
trial
train
trial
longterm
memori
figur
panel
c
open
field
test
detect
genotyp
effect
locomotor
activ
stereotypi
litterm
display
increas
hyperlocomot
quantifi
increas
total
distanc
travel
measur
centimet
accompani
increas
overal
stereotyp
movement
rear
detect
chang
hyperact
stereotyp
vertic
activ
knockdown
mice
follow
pioglitazon
treatment
figur
panel
bd
elev
plu
maze
detect
effect
genotyp
p
knockdown
anim
spent
significantli
time
open
arm
wt
mice
regardless
pioglitazonevehicl
treatment
figur
increas
time
open
arm
indic
lack
anxieti
observ
mous
model
manialik
behavior
detect
signific
differ
genotyp
drug
treatment
social
paradigm
figur
detect
differ
acoust
startl
respons
group
although
knockdown
anim
tend
higher
startl
respons
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
big
biomed
data
resourc
linc
open
new
avenu
innov
analys
primari
data
gener
conjunct
focus
hypothesi
driven
research
undertaken
individu
research
lab
interdisciplinari
studi
combin
resourc
research
expertis
neurosci
bioinformat
data
scienc
greatli
enhanc
abil
gener
novel
hypothes
offer
key
insight
mechan
human
diseas
goal
studi
part
first
character
chang
glycolyt
enzym
express
cellular
level
schizophrenia
explor
find
avail
silico
databas
second
analyz
connect
bioenerget
patholog
schizophrenia
gener
schizophrenia
bioenerget
profil
ilinc
perform
pathway
analys
panel
cluster
gene
highli
differenti
express
across
knockdown
signatur
third
gener
list
promis
drug
intervent
goal
futur
preclin
test
fourth
examin
endophenotyp
schizophrenia
follow
treatment
fda
approv
drug
identifi
bioinformat
analys
anim
model
find
decreas
pfkl
gpi
mrna
pyramid
neuron
build
upon
previou
report
abnorm
glycolyt
enzym
well
glucoselact
transport
dlpfc
schizophrenia
pfkl
code
liver
l
subunit
pfk
enzym
catalyz
phosphoryl
fructos
fructos
third
irrevers
ratelimit
step
glycolysi
sever
tetramer
isoform
pfk
enzym
compris
differ
combin
l
muscl
platelet
p
subunit
protein
entir
compris
l
subunit
protein
entir
compris
subunit
erythrocyt
pfk
enzym
contain
heterogen
composit
pfk
enzym
found
brain
condit
high
glycolyt
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
flux
cell
divert
glucos
pentos
phosphat
pathway
howev
convers
fructos
fructos
pfk
commit
glucos
glycolyt
pathway
gatekeep
metabol
degrad
glucos
pfk
highli
regul
downstream
metabolit
strong
alloster
activ
fructos
produc
pfkfb
glycolysi
upregul
warburg
effect
notabl
knockdown
pfkl
impair
glycolysi
promot
metabol
via
pentos
phosphat
pathway
decreas
pfkl
pfkm
express
schizophrenia
could
affect
normal
enzym
activ
result
either
decreas
glycolyt
breakdown
glucos
inabl
upregul
glycolysi
energi
demand
high
interestingli
human
pfkl
gene
locat
chromosom
abnorm
express
pfkl
associ
syndrom
addit
previous
report
decreas
pfk
activ
dlpfc
schizophrenia
subject
also
found
decreas
mrna
express
gpi
enrich
popul
pyramid
neuron
schizophrenia
gpi
dimer
cytoplasm
enzym
catalyz
revers
isomer
second
step
glycolyt
pathway
express
extracellularli
gpi
protein
function
neurotroph
factor
promot
neuron
surviv
one
studi
found
increas
level
well
sever
metabolit
glycolyt
pathway
peripher
blood
mononuclear
cell
schizophrenia
patient
suggest
improp
function
glycolyt
enzym
data
suggest
gpi
defici
result
accumul
activ
mammalian
target
rapamycin
mtor
pathway
decreas
gpi
express
pyramid
neuron
could
contribut
dysregul
glycolysi
mtor
signal
disrupt
mtor
signal
could
affect
protein
synthesi
lead
aberr
neuron
growth
synaps
connect
support
hypothesi
mtor
pathway
previous
implic
schizophrenia
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
base
strong
celllevel
evid
studi
prior
work
well
decreas
glycolyt
enzym
activ
gener
schizophrenia
bioenerget
profil
consist
function
relat
gene
gene
seed
gene
strong
glycolysi
regul
critic
step
glycolyt
pathway
seed
gene
profil
use
lookup
replic
studi
ilinc
cluster
ilinc
connect
drug
discoveri
analys
sought
replic
metabol
lcm
find
well
explor
mrna
express
seed
gene
silico
lookup
analys
lcm
studi
found
decreas
pfkm
pfkl
gpi
pyramid
neuron
dlpfc
schizophrenia
figur
tabl
probe
second
celllevel
dataset
frontal
cortic
neuron
differenti
ipsc
schizophrenia
subject
disc
mutat
found
seed
gene
abnorm
express
ldha
pfkm
pfkl
gpi
tabl
ldha
previous
found
downregul
dentat
granul
neuron
schizophrenia
also
significantli
downregul
smri
genom
databas
also
found
genet
link
schizophrenia
downregul
schizophrenia
mssm
dlpfc
microarray
data
smri
mssm
databas
contain
regionlevel
find
multipl
brain
region
ipsc
lcm
techniqu
provid
cellsubtyp
specif
resolut
prior
work
laboratori
found
decreas
pfk
hk
enzym
activ
level
dlpfc
schizophrenia
find
suggest
seed
gene
dysregul
cell
region
transcript
function
level
schizophrenia
well
genet
associ
use
ilinc
http
ilincsorg
retriev
knockdown
signatur
seed
gene
individu
seed
gene
knockdown
signatur
gpi
knockdown
signatur
knockdown
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
signatur
pfkm
knockdown
signatur
pfkl
knockdown
signatur
ldha
knockdown
signatur
knockdown
signatur
compris
transcript
chang
landmark
gene
gene
seed
gene
knock
figur
cluster
knockdown
signatur
seed
gene
ilinc
separ
select
panel
cluster
upregul
downregul
gene
use
interact
dendrogram
function
result
upregul
downregul
gene
carri
forward
enrichr
analys
began
use
enrichr
identifi
pathway
associ
panel
cluster
upregul
gene
ilinc
cluster
analysi
figur
figur
use
kegg
gener
top
cell
signal
pathway
return
hit
foxo
wnt
mapk
signal
signal
pathway
implic
glucos
util
energi
homeostasi
mitochondri
function
cell
growth
top
proteinprotein
interact
hit
glycogen
synthas
kinas
beta
cyclin
depend
kinas
etc
suggest
role
pathway
involv
energi
metabol
cell
prolifer
next
probe
kinas
knock
specif
cell
line
increas
express
gene
panel
cluster
upregul
gene
found
sever
serinethreonineprotein
kinas
includ
atr
one
close
relat
serinethreonineprotein
kinas
thought
regul
metabol
promot
cellular
prolifer
also
signific
hit
gprotein
coupl
receptor
protein
neuromedin
u
encod
gprotein
coupl
receptor
protein
wide
express
central
nervou
system
cn
bind
neuropeptid
neuromedin
u
order
regul
energi
homeostasi
result
suggest
kinas
involv
glucos
metabol
cell
cycl
regul
relev
panel
cluster
upregul
gene
final
perform
pathway
analys
identifi
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
transcript
factor
occup
site
panel
cluster
upregul
gene
sever
play
key
role
neurodevelop
nfib
etc
transcript
factor
analysi
also
gener
hit
estrogen
receptor
tumor
suppressorsactiv
transcript
factor
involv
immun
respons
macrophag
function
cebpb
enrichr
analys
summar
tabl
full
discuss
panel
cluster
upregul
gene
found
supplement
use
enrichr
identifi
pathway
associ
panel
cluster
downregul
gene
ilinc
cluster
analysi
figur
figur
use
kegg
gener
top
cell
signal
pathway
return
hit
htlv
infect
hepat
b
signal
cell
cycl
pathway
figur
implic
inflamm
impair
immun
cell
prolifer
top
hit
go
cellular
compon
analysi
panel
cluster
downregul
gene
implic
mitochondria
oxid
phosphoryl
figur
top
hit
proteinprotein
interact
analysi
figur
panel
cluster
downregul
gene
includ
histon
deacetylas
ubiquit
express
protein
remov
acetyl
group
lysin
residu
core
histon
top
hit
proteinprotein
interact
analysi
includ
prolifer
cell
nuclear
antigen
pcna
also
bind
involv
epigenet
dna
replic
dna
repair
interestingli
increas
prefront
cortex
hippocampu
schizophrenia
overexpress
lead
impair
work
memori
accumul
instanc
schizophrenia
patient
mutat
gene
encod
chromatin
regul
histon
modifi
enzym
transcript
factor
hit
includ
transcript
factor
involv
inflamm
balanc
activ
suppress
cellular
prolifer
process
next
probe
kinas
knock
specif
cell
line
decreas
express
gene
panel
cluster
downregul
gene
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
found
multipl
kinas
import
role
glucos
homeostasi
energi
metabol
nuclear
receptor
form
heterodim
retinoid
x
receptor
rxr
two
top
hit
increas
transcript
variou
gene
stimul
glucos
uptak
carbohydr
metabol
ligand
thiazolidinedion
tzd
increas
glucos
util
treat
hyperglycemia
repres
therapeut
possibl
diseas
defici
glycolyt
system
also
found
kinas
involv
axon
growth
cn
develop
ryk
cell
growth
cycl
progress
cytoskelet
remodel
final
perform
pathway
analys
identifi
transcript
factor
occup
site
panel
cluster
downregul
gene
sever
play
key
role
cellular
proliferationdevelop
similar
hit
previou
analys
myc
mycn
forkhead
box
figur
enrichr
analys
summar
tabl
full
discuss
panel
cluster
downregul
gene
found
supplement
summari
extrapol
abnorm
glycolyt
enzym
use
enrichr
pathway
analys
panel
cluster
downregul
gene
analys
yield
addit
pathway
regul
involv
cellular
process
cell
cycl
regul
inflammatori
respons
inappropri
cell
cycl
regul
could
contribut
metabol
deficit
immun
system
previous
implic
schizophrenia
sever
metabol
immun
find
replic
larg
scale
transcriptom
bioinformat
analys
psychiatr
disord
result
highlight
connect
glycolyt
patholog
schizophrenia
sever
system
could
import
target
futur
studi
divid
top
uniqu
perturbagen
signatur
connect
analysi
group
ppar
agonist
inhibitor
antipsychot
drug
hdac
inhibitor
tabl
inhibitor
constitut
drug
may
revers
diseas
signatur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
antitumor
drug
inhibit
enzym
part
signal
pathway
play
critic
role
mani
cellular
function
cellular
prolifer
metabol
immun
cell
activ
recent
work
link
schizophrenia
patholog
signal
cascad
addit
signal
modul
synapt
format
plastic
implic
schizophrenia
autism
disord
review
previou
work
demonstr
pharmacolog
inhibit
catalyt
subunit
block
amphetamin
induc
psychosi
mice
highlight
inhibitor
therapeut
target
treatment
psychiatr
disord
howev
inhibit
may
suitabl
posit
symptom
inhibit
result
diminish
insulinstimul
glucos
uptak
inhibit
transloc
glucos
transport
plasma
membran
three
drug
discoveri
analysi
hit
typic
antipsychot
also
treat
posit
symptom
schizophrenia
via
dopamin
receptor
antagon
possibl
glycolyt
knockdown
signatur
use
gener
perturbagen
could
caus
transcript
chang
gene
involv
regul
dopaminerg
synaps
suggest
dopamin
metabol
system
could
connect
schizophrenia
entir
surpris
antipsychot
well
document
metabol
effect
top
uniqu
perturbagen
signatur
connect
analysi
tabl
valproic
acid
hdac
inhibitor
modul
sodium
channel
enhanc
gammaaminobutyr
acid
gaba
mediat
neurotransmiss
tradit
use
treat
epilepsi
bipolar
disord
interestingli
sodium
valproat
valproic
acid
commonli
use
adjunct
therapi
treatment
schizophrenia
recent
week
random
clinic
trial
demonstr
improv
psychopatholog
combin
therapi
valproat
risperidon
olanzapin
compar
antipsychot
alon
also
evid
posit
effect
aggress
tardiv
dyskinesia
schizophrenia
although
sampl
size
small
valproic
acid
also
affect
erk
wnt
pathway
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
implic
pathway
analys
regul
cell
surviv
cytoskelet
modif
stimul
abil
enhanc
transcript
activ
ppar
increas
glucos
metabol
indic
ppar
agonist
might
also
potenti
therapeut
target
interestingli
two
uniqu
perturbagen
hit
includ
ppar
agonist
troglitazon
genistein
troglitazon
part
tzd
famili
antiinflammatori
antidiabet
drug
develop
treat
type
diabet
troglitazon
ligand
strongli
promot
glucos
uptak
increas
two
transport
previous
found
decreas
pyramid
neuron
schizophrenia
inhibit
proinflammatori
factor
nfkb
implic
enrichr
analys
tzd
famili
ppar
agonist
present
interest
therapeut
intervent
studi
preclin
model
schizophrenia
due
abil
modul
glucos
system
find
abnorm
schizophrenia
pioglitazon
current
fda
approv
member
tzd
famili
also
stimul
glycolyt
system
attenu
mitochondri
dysfunct
revers
memori
impair
decreas
incid
dementia
thu
pioglitazon
easili
access
drug
candid
revers
patholog
possibl
restor
cognit
defect
relat
schizophrenia
test
hypothesi
first
examin
metabol
pathway
knockdown
model
schizophrenia
knockdown
anim
display
wide
varieti
endophenotyp
associ
schizophrenia
includ
deficit
cognit
found
top
pathway
associ
protein
chang
synaps
knockdown
mice
compar
wt
control
metabol
natur
figur
addit
express
glucos
transport
significantli
decreas
frontal
cortex
knockdown
mice
figur
result
suggest
similar
abnorm
bioenerget
system
model
schizophrenia
modul
system
viabl
treatment
strategi
thu
examin
effect
pioglitazon
ppar
agonist
increas
glucos
uptak
behavior
endpoint
knockdown
model
pharmacolog
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
manipul
glycolyt
pathway
via
pioglitazon
could
stimul
glucos
uptak
metabol
possibl
restor
behavior
deficit
also
abl
control
medic
treatment
difficult
interpret
human
studi
import
distinguish
signific
metabol
chang
underli
featur
ill
epiphenomena
relat
treatment
antipsychot
hypothes
pioglitazon
treatment
would
improv
cognit
function
knockdown
model
puzzl
box
assay
examin
cognit
function
progress
difficult
evid
similarli
poor
perform
group
later
trial
howev
earlier
trial
deficit
robust
pioglitazon
tend
increas
wt
mean
latenc
decreas
knockdown
mean
latenc
statist
analys
found
trial
trial
pioglitazon
significantli
decreas
latenc
perform
task
knockdown
mice
figur
panel
c
suggest
normal
physiolog
pioglitazon
could
neg
effect
learn
patholog
brain
impair
synaps
pioglitazon
may
restor
effect
cognit
also
examin
effect
pioglitazon
behavior
reflect
posit
neg
schizophrenia
symptom
line
publish
find
model
data
suggest
knockdown
anim
increas
locomotor
activ
stereotypi
compar
wt
litterm
control
well
increas
mania
antianxieti
like
behavior
increas
time
spent
open
arm
epm
compar
wt
mice
figur
pioglitazon
effect
behavior
regardless
genotyp
suggest
either
glucos
metabol
play
role
phenotyp
knockdown
mice
neurodevelopment
phenotyp
requir
earlier
intervent
detect
chang
sociabl
group
group
choos
spend
time
social
zone
figur
previou
studi
demonstr
inher
social
abnorm
knockdown
mice
suggest
experi
may
underpow
detect
effect
sociabl
also
detect
chang
social
novelti
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
howev
social
novelti
data
high
variabl
could
contribut
lack
signific
find
final
assess
sensorimotor
gate
use
prepuls
inhibit
acoust
startl
respons
figur
find
suggest
pioglitazon
may
select
exert
effect
specif
endophenotyp
schizophrenia
suggest
circuitspecif
modul
neuroplast
substrat
one
possibl
pioglitazon
improv
function
brain
region
circuit
hypometabol
effectneg
consequ
brain
region
normal
hypermetabol
mani
behavior
endpoint
marker
posit
symptom
schizophrenia
could
correspond
hypermetabol
circuitri
thu
amen
rescu
via
pioglitazon
found
pioglitazon
effect
behavior
deficit
hyperact
increas
stereotypi
social
impair
normal
typic
atyp
antipsychot
knockdown
anim
howev
pioglitazon
restor
effect
cognit
puzzl
box
assay
typic
antipsychot
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
studi
examin
effect
antipsychot
treatment
cognit
knockdown
anim
yet
done
warrant
cognit
includ
sever
subprocess
uniqu
sustain
frontal
cortex
also
distribut
cortic
network
includ
frontal
region
may
associ
frontal
lobe
process
includ
task
manag
plan
flexibl
behavior
thought
work
memori
attent
other
thu
poor
perform
paramet
could
reflect
number
possibl
cognit
mechan
instanc
two
metaanalys
cannabi
use
cognit
schizophrenia
demonstr
cannabi
improv
certain
subtask
element
cognit
visual
memori
plan
work
memori
effect
worsen
task
attent
verbal
memori
process
speed
also
possibl
pioglitazon
may
improv
metabol
subtyp
schizophrenia
support
lcm
qpcr
studi
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
find
also
justifi
futur
pioglitazon
studi
examin
differ
type
memori
exampl
pioglitazon
may
independ
influenc
associ
learn
spatial
work
memori
cognit
flexibl
longterm
memori
recognit
memori
pioglitazon
also
fda
approv
drug
human
trial
examin
pioglitazon
antipsychot
treatment
larger
number
specif
cognit
aspect
would
use
could
achiev
measur
stroop
wordcolor
task
select
attent
n
back
test
backward
digit
span
test
work
memori
brownpeterson
test
memori
capac
wisconsin
card
sort
plan
setshift
indic
cognit
verbal
comprehens
index
vci
perceptu
organiz
index
poi
work
memori
index
wmi
process
speed
index
psi
immedi
memori
index
imi
gener
memori
index
use
human
cognit
batteri
summari
data
suggest
pioglitazon
may
impact
specif
element
cognit
model
schizophrenia
bioinformat
approach
potenti
offer
key
insight
understand
specif
human
diseas
healthi
state
manifest
howev
techniqu
present
sever
limit
pathway
analys
inher
bias
enrichr
limit
previous
publish
experi
mean
system
extens
studi
may
skew
result
addit
select
panel
cluster
gene
input
enrichr
use
dendrogram
cluster
figur
figur
uncommon
knockdown
signatur
chang
direct
gene
knockdown
signatur
chang
chang
opposit
direct
howev
sinc
goal
studi
analyz
aggreg
signatur
select
cluster
gene
larg
chang
togeth
direct
enrichr
merg
human
mous
rat
data
approach
advantag
disadvantag
comprehens
librari
lack
speci
specif
chemic
perturbagen
analys
two
seed
gene
pfkl
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
strongest
discord
perturbagen
signatur
tabl
lead
overrepresent
two
seed
gene
overal
top
chemic
perturbagen
tabl
tabl
especi
true
fundament
aspect
cellular
biolog
includ
energi
metabol
relat
pathway
consid
linc
databas
includ
landmark
gene
select
provid
repres
class
coexpress
gene
enabl
imput
level
express
gene
measur
directli
may
instanc
panel
fulli
captur
chang
found
diseas
state
silico
lookup
analys
metabol
target
schizophrenia
also
present
challeng
smri
databas
analysi
function
perform
metaanalysi
across
independ
studi
combin
molecularli
function
distinct
brain
region
possibl
gene
region
cerebellum
drive
result
subtl
differ
cortic
region
report
addit
smri
mssm
databas
gener
whole
brain
region
cellsubtyp
specif
surpris
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mani
cellsubtyp
specif
find
appreci
regionlevel
lookup
confirm
studi
gene
express
may
increas
certain
cell
type
decreas
other
net
chang
smri
databas
particularli
rais
concern
due
number
individu
studi
use
comparison
mani
vari
subject
demograph
notion
support
observ
mani
target
differenti
regul
celllevel
frontal
cortic
neuron
databas
limit
asid
interest
probe
dataset
publicli
access
databas
target
pathway
implic
enrichr
analys
tabl
knockdown
work
without
limit
locomotor
cognit
assay
adequ
power
per
group
elev
plu
maze
social
paradigm
ppi
studi
averag
mice
per
group
may
larg
enough
fulli
elucid
subtl
behavior
differ
also
possibl
pioglitazon
dose
use
may
fulli
produc
therapeut
effect
futur
work
vari
dose
regimen
warrant
addit
discuss
cognit
multifacet
current
studi
util
one
approach
examin
execut
function
puzzl
box
assay
sever
behavior
task
fear
condit
learn
context
versu
cue
water
maze
contextu
memori
radial
arm
maze
work
memori
novel
object
task
would
use
determin
nuanc
effect
pioglitazon
final
addit
biochem
experi
knockdown
mice
could
help
elucid
potenti
metabol
pathway
target
would
provid
framework
futur
intervent
studi
use
promis
new
prometabol
drug
knockdown
mice
pioglitazon
model
schizophrenia
ie
pharmacolog
mutant
etc
revers
translat
approach
could
also
gener
target
question
futur
postmortem
work
summari
util
linc
librari
genet
chemic
perturb
coupl
novel
bioinformat
approach
gain
insight
connect
bioenerget
patholog
schizophrenia
gener
candid
drug
potenti
revers
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
connect
patholog
signatur
oppos
singl
target
restor
longterm
memori
ppar
agonist
pioglitazon
preclin
model
schizophrenia
work
highlight
potenti
bioinformat
analys
identifi
novel
treatment
strategi
disord
cognit
difficult
treat
clinic
domain
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
dorsolater
prefront
cortex
dlpfc
brodmann
area
postmortem
brain
sampl
origin
maryland
brain
collect
distribut
maryland
brain
collect
alabama
brain
collect
cohort
consist
subject
schizophrenia
nonpsychiatr
ill
comparison
subject
tabl
subject
diagnos
schizophrenia
base
dsmiv
criteria
medic
record
subject
examin
use
formal
blind
medic
chart
review
instrument
well
person
interview
subject
andor
caregiv
previous
describ
schizophrenia
comparison
group
match
sex
age
ph
pmi
tabl
lcm
perform
previous
describ
briefli
frozen
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cell
popul
cell
captur
hour
session
previous
demonstr
time
frame
minim
effect
messeng
rna
integr
follow
cell
captur
cap
incub
picopur
rna
extract
buffer
molecular
devic
sunnyval
ca
usa
min
c
sampl
centrifug
min
g
store
process
rna
treat
rnasefre
dnase
qiagen
nl
process
rna
reversetranscrib
use
highcapac
cdna
archiv
kit
appli
biosystem
foster
citi
ca
usa
pcr
experi
sampl
preamplifi
previous
describ
began
select
gene
interest
schizophrenia
pathophysiolog
build
bioenerget
schizophrenia
profil
select
target
glycolyt
pathway
select
downregul
studi
previou
studi
gpi
pfkm
pfkl
well
dysregul
literatur
ldha
tabl
knockdown
signatur
retriev
seed
gene
ilinc
knockdown
signatur
use
subsequ
lookup
replic
ilinc
cluster
enrichr
ilinc
connect
drug
discoveri
analys
replic
bioenerget
find
schizophrenia
probe
publicli
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
schizophrenia
control
subject
rnaseq
databas
contain
data
frontal
cortic
neuron
differenti
ipsc
schizophrenia
subject
disc
mutat
unaffect
sibl
control
subject
report
fold
chang
pvalu
metabol
target
tabl
use
ilinc
http
ilincsorg
retriev
knockdown
signatur
seed
gene
goal
identifi
panel
correl
transcriptom
chang
seed
gene
knockdown
signatur
use
ilinc
perform
unsupervis
cluster
top
differenti
express
gene
seed
gene
knockdown
signatur
maximum
gene
figur
figur
due
gene
overlap
top
differenti
express
gene
seed
gene
knockdown
signatur
result
cluster
express
data
gene
gener
heatmap
use
interact
gene
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cluster
function
ilinc
cluster
express
data
differenti
express
gene
use
pearson
correl
coeffici
union
top
differenti
express
gene
use
yaxi
dendrogram
function
select
gene
display
similar
chang
express
across
signatur
refer
gene
upregul
across
signatur
panel
cluster
upregul
gene
gene
downregul
across
signatur
panel
cluster
downregul
gene
panel
cluster
upregul
panel
cluster
downregul
gene
group
select
separ
data
export
excel
tabl
figur
figur
cluster
gene
panel
tabl
carri
forward
two
separ
enrichr
analys
assess
biolog
underpin
correl
transcript
chang
seed
gene
knockdown
signatur
ilinc
perform
tradit
pathway
analys
panel
cluster
upregul
panel
cluster
downregul
gene
use
enrichr
http
amppharmmssmeduenrichr
tabl
figur
analys
panel
cluster
upregul
gene
gene
panel
cluster
downregul
gene
gene
perform
separ
report
result
kegg
cell
signal
pathway
gene
ontolog
go
molecular
function
go
cellular
compon
proteinprotein
interact
partner
dbgap
diseas
implic
use
chea
databas
enrichr
also
report
transcript
factor
occup
site
signific
number
panel
cluster
gene
final
use
linc
databas
enrichr
report
kinas
knock
specif
cell
line
increas
decreas
gene
panel
cluster
upregul
downregul
gene
data
set
respect
tabl
figur
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
goal
identifi
small
druglik
molecul
invers
signatur
probe
ilinc
chemic
perturbagen
result
transcriptom
signatur
highli
discord
anticorrel
denot
neg
concord
valu
seed
gene
knockdown
signatur
potenti
revers
seed
gene
knockdown
signatur
done
individu
seed
gene
knockdown
signatur
unclust
top
discord
chemic
perturbagen
signatur
record
tabl
discord
signatur
gpi
pfkm
less
perturbagen
appear
multipl
time
seed
gene
either
differ
cell
line
administ
cell
differ
concentr
also
record
top
overal
discord
chemic
perturbagen
signatur
across
seed
gene
knockdown
signatur
tabl
top
overal
discord
chemic
perturbagen
signatur
vcap
cell
line
duplic
remov
uniqu
discord
chemic
perturbagen
signatur
remain
tabl
list
use
select
fda
approv
drug
preclin
trial
anim
hous
experiment
carri
accord
canadian
council
anim
care
ccac
guidelin
care
use
anim
mice
group
hous
litterm
lightdark
cycl
given
access
food
teklad
global
protein
rodent
diet
envigo
madison
wisconsin
usa
wwwenvigocom
ad
libitum
unless
otherwis
specifi
mice
tail
clip
toe
tattoo
day
genotyp
wean
toe
tattoo
use
identifi
experi
mice
knockdown
mice
gener
hous
describ
previous
insert
mutat
neo
identifi
use
follow
primer
wildtyp
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
lcmsipa
qpcr
studi
knockdown
wt
mice
open
field
test
puzzl
box
assay
pioglitazon
studi
total
anim
wt
knockdown
mice
tabl
elev
plu
maze
social
paradigm
ppi
pioglitazon
studi
total
anim
wt
knockdown
mice
tabl
use
mous
antibodi
millipor
catalogu
captur
protein
complex
sampl
male
wt
male
knockdown
verifi
specif
antibodi
use
multipl
reaction
monitor
mass
spectrometri
analysi
peptid
captur
affin
purif
antibodi
coupl
per
dynabead
life
technolog
accord
antibodi
coupl
kit
protocol
sampl
antibodi
coupl
bead
wash
ice
cold
pbst
cell
signal
incub
mous
brain
lysat
brought
final
volum
ice
cold
pbst
hour
room
temperatur
supernat
remov
bead
wash
x
minut
room
temperatur
ice
cold
pbst
captur
protein
complex
elut
ammonium
hydroxid
sigma
edta
ph
minut
room
temperatur
protein
denatur
buffer
sd
bromophenol
blue
glycerol
mm
trishcl
ph
ad
sampl
elut
elut
sampl
heat
minut
process
mass
spectrometri
sampl
male
wt
male
knockdown
load
mm
bistri
invitrogen
nupag
gel
electrophores
me
buffer
minut
gel
fix
acet
acid
overnight
rt
wash
ethanol
min
follow
two
min
wash
milliq
water
milliq
gradient
system
lane
harvest
cut
small
squar
subject
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ingel
tryptic
digest
peptid
recoveri
repres
western
blot
seen
figur
sampl
resuspend
formic
acid
nano
liquid
chromatographi
coupl
electrospray
tandem
mass
spectrometri
nlcesimsm
analys
perform
qtof
mass
spectromet
sciex
toronto
canada
interfac
eksig
dublin
ca
nanolcultra
nanoflow
system
peptid
load
via
eksig
autosampl
onto
integrafrit
trap
column
outer
diamet
inner
diamet
pack
bed
new
object
inc
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
charg
state
high
sensit
mode
roll
collis
energi
collis
energi
spread
ce
v
select
protal
dia
softwar
vulcan
analyt
birmingham
al
use
analyz
everi
dia
file
sciex
qtof
swissprot
homo
sapien
databas
download
march
th
use
refer
databas
msm
search
precursor
fragment
toler
qtof
instrument
use
protal
caterpillar
spectrallibrari
free
identif
algorithm
potenti
modif
includ
search
phosphoryl
residu
ntermin
acetyl
ntermin
loss
ammonia
c
residu
pyroglutam
acid
ntermin
e
q
residu
carbamidomethyl
c
residu
search
fix
modif
maximum
valid
protein
peptid
expect
score
x
tandem
search
engin
use
peptid
protein
identif
reconstruct
spectra
set
dia
quantif
protal
maximum
number
b
seri
fragment
transit
set
nine
exclud
mz
valu
contain
least
rel
intens
strongest
fragment
assign
peptid
minimum
five
fragment
requir
peptid
quantifi
except
indic
otherwis
dataset
minimum
seven
consist
fragment
detect
peptid
ion
three
file
compar
triplic
analysi
algorithm
identifi
file
largest
sum
fragment
auc
extract
seven
file
use
normal
retent
time
coordin
base
peptid
detect
caterpillar
algorithm
file
dataset
gener
top
pathway
knockdown
mice
input
top
increas
protein
knockdown
mice
rel
wt
mice
lcm
experi
ingenu
pathway
analysi
ipa
top
implic
pathway
report
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
experi
day
food
also
weigh
throughout
experi
figur
day
mice
locomotor
activ
stereotypi
behavior
measur
open
field
test
day
mice
test
elev
plu
maze
epm
day
mice
test
puzzl
box
assay
day
mice
subject
social
affili
paradigm
final
day
prepuls
inhibit
test
timet
present
tabl
locomotor
activ
stereotypi
measur
use
digit
activ
monitor
omnitech
electron
columbu
oh
usa
first
day
behavior
test
day
overal
experiment
paradigm
previous
describ
mice
place
novel
plexigla
arena
x
x
cm
locomotor
stereotyp
activ
record
period
dim
light
activ
track
via
infrar
light
beam
sensor
total
distanc
travel
stereotyp
movement
collect
bin
anxieti
behavior
assess
day
test
via
elev
plu
maze
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mice
run
puzzl
box
assay
day
test
assess
cognit
execut
function
previous
describ
consist
two
compart
puzzl
box
contain
start
area
x
x
cm
bright
light
goal
zone
x
x
cm
dim
light
two
area
separ
black
plexigla
divid
connect
via
underpass
larg
enough
mice
pass
easili
mice
place
start
box
face
away
divid
time
move
goal
zone
underpass
hind
leg
goal
zone
manual
score
record
mice
test
three
day
trialsday
day
consist
increasingli
difficult
obstacl
present
underpass
connect
start
area
goal
zone
min
given
trial
given
day
max
sec
allow
complet
trial
trial
obstacl
puzzl
box
follow
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
social
stimulu
novel
wildtyp
inbr
mice
ageand
sexmatch
test
mous
prepuls
inhibit
acoust
startl
respons
measur
day
via
srlab
equip
softwar
san
diego
instrument
san
diego
instrument
san
diego
ca
usa
acceleromet
calibr
mv
output
voltag
amplifi
analyz
voltag
chang
use
sr
analysi
export
excel
file
background
white
nois
maintain
ppi
measur
test
random
trial
trial
puls
alon
trial
prepuls
alon
prepuls
trial
prepuls
plu
puls
prepuls
trial
puls
puls
alon
trial
perform
trial
total
trial
per
run
prepuls
present
prior
startl
puls
interstimulu
interv
isi
random
experiment
mice
place
cylindr
tube
platform
soundproof
chamber
mice
allow
acclimat
chamber
background
nois
follow
consecut
puls
alon
trial
random
trial
describ
consecut
puls
alon
trial
prepuls
inhibit
measur
decreas
amplitud
startl
respons
acoust
startl
puls
follow
prepuls
statist
analys
human
lcmqpcr
follow
data
analyz
use
outlier
remov
data
set
use
rout
method
q
depend
measur
test
normalci
homogen
varianc
use
dagostino
pearson
omnibu
normal
test
follow
student
ttest
probe
associ
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
depend
measur
ph
pmi
age
rin
use
correl
analys
detect
signific
correl
age
ph
pmi
depend
measur
addit
postmortem
interv
ph
age
perform
secondari
analys
use
ttest
examin
ethanol
use
smoke
later
group
variabl
schizophrenia
subject
found
signific
effect
also
perform
ttest
remov
antipsychot
subject
target
remain
signific
subject
depend
cocain
sed
cannabi
amphetamin
hallucinogen
inhal
opioid
depend
subject
took
morphin
pain
subject
prolong
agon
state
includ
cohort
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
differenti
express
gene
seed
gene
kd
signatur
panel
cluster
differenti
express
gene
carri
forward
enrichr
analys
also
perform
ilinc
connect
analys
identifi
peroxisom
proliferatoractiv
receptor
ppar
agonist
promis
therapeut
target
potenti
revers
glycolyt
deficit
well
associ
chang
gene
final
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
type
pfkm
g
isomeras
gpi
lactat
dehydrogenas
ldha
hexokinas
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
isomeras
gpi
lactat
dehydrogenas
ldha
hexokinas
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
tabl
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
denot
unavail
p
statist
due
low
subject
number
denot
multipl
affi
probe
gene
geomean
use
calcul
fold
chang
p
fc
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
tabl
top
uniqu
chemic
perturbagen
top
uniqu
chemic
perturbagen
abil
revers
schizophrenia
bioenerget
profil
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
